Marie Novello

1PUBLICATIONS
9CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Nov 06, 2021
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions.

Sonia Brun, Eloïne Bestion, Eric Raymond

Pageof 1

Frequent Collaborators

1 joint publications

Sonia Brun

1 joint publications

Eloïne Bestion

1 joint publications

Eric Raymond

1 joint publications

Zuzana Macek Jilkova

1 joint publications

Soraya Mezouar

1 joint publications

Gilles Lalmanach

1 joint publications

Gael Roth

1 joint publications

Jean-Pierre Baudoin

1 joint publications

Thomas Decaens

Frequent Collaborators

1 joint publications

Sonia Brun

1 joint publications

Eloïne Bestion

1 joint publications

Eric Raymond

1 joint publications

Zuzana Macek Jilkova

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.8K
See more related videos

Top Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on : Jul 12, 2018

8.8K
See more related videos